Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
18.23
+1.41 (8.38%)
At close: Oct 7, 2025, 4:00 PM EDT
18.01
-0.22 (-1.21%)
After-hours: Oct 7, 2025, 4:02 PM EDT
Scilex Holding Company Employees
Scilex Holding Company had 115 employees as of December 31, 2024. The number of employees increased by 10 or 9.52% compared to the previous year.
Employees
115
Change (1Y)
10
Growth (1Y)
9.52%
Revenue / Employee
$384,661
Profits / Employee
-$1,069,470
Market Cap
100.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 115 | 10 | 9.52% |
| Dec 31, 2023 | 105 | 15 | 16.67% |
| Dec 31, 2022 | 90 | 14 | 18.42% |
| Dec 31, 2021 | 76 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCLX News
- 6 days ago - Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase - GlobeNewsWire
- 11 days ago - Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company - Business Wire
- 11 days ago - Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI - GlobeNewsWire
- 12 days ago - Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI - GlobeNewsWire
- 12 days ago - Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin - GlobeNewsWire
- 13 days ago - Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management - GlobeNewsWire
- 14 days ago - Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Semnur Common Stock in Exchange for $100 Million in Bitcoin - GlobeNewsWire
- 14 days ago - Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin - GlobeNewsWire